Europeanhhm

RapidAI Receives FDA Clearance for Perfusion Imaging Integration in Angiography Suites

Tuesday, May 07, 2024

RapidAI, a prominent developer of Artificial Intelligence (AI) solutions for combatting critical neurovascular, cardiac, and vascular diseases, has recently announced FDA clearance for its AngioFlow™ solution through the 510(k) process.

This solution is designed to provide perfusion imaging analysis directly within the interventional suite, aiming to boost clinical confidence, streamline workflows, and potentially enhance patient outcomes.

RapidAI's CEO, expressed satisfaction with the expansion of their stroke AI imaging portfolio to incorporate the AngioFlow™ module. Karti emphasized the significance of covering the entire patient pathway, from initial non-contrast CT scans to the interventional suite.

Notably, this technology has already been adopted in Japan and Europe, with Karti believing it will make a substantial difference for stroke patients in the U.S.

In acute stroke care, where time is critical, prompt intervention can be life-saving and reduce the risk of long-term disability. AngioFlow™ by RapidAI, utilized by care teams in the interventional suite, offers qualitative perfusion maps within minutes, assisting specialists in evaluating ischemic changes in brain regions with reduced cerebral blood flow.

This solution is expected to enhance operational efficiency and financial value by minimizing redundant imaging and potentially saving time in patient care.

Conducting imaging at a referring facility enables physicians to assess the necessity for additional scans in the interventional suite, expediting clinical decisions and reducing unnecessary imaging. This holds particular importance in rural facilities and large hospital networks, where patient transfers can be time-consuming.

Creighton University School of Medicine in Omaha, Nebraska, highlighted that AngioFlow™ by RapidAI facilitates immediate assessment of the need for additional imaging in the interventional suite.

By avoiding unnecessary scans, stroke patients can receive timely care, potentially influencing their ability to return home rather than being discharged to a skilled nursing facility.




Source: businesswire.com

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024